PHENAZOPYRIDINE HCL Tablet Maximum Strength

Manufacturer
Safrel Pharmaceuticals, LLC.
Effective date
2022-08-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:50:24

Label at a glance#

ProductUrinary Pain Relief
Active ingredientPHENAZOPYRIDINE HYDROCHLORIDE
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)

Phenazopyridine Hydrochloride 99.5 mg

OTC - PURPOSE SECTION

Purpose

Urinary Tract Analgesic

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of an overdose, get medical help or contact poison Control Center right away.

INDICATIONS & USAGE SECTION

Use Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.

WARNINGS SECTION

Please read insert for important precautions.

Ask a doctor before use if you have:

■ kidney disease

■ allergies to foods, preservatives or dyes

■ had a hypersensitive reaction to Phenazopyridine Hydrochloride

Do not use if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.

When using this product

■ stomach upset may occur, taking this product with or after meals may reduce stomach upset

■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

Stop use and ask a doctor if

■ your symptoms last for more than 2 days

■ you suspect you are having an adverse reaction to the medication

■ Long-term adminitration of phenazopyridine hydrochloride has induced neoplasia in rats (large instestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human enoplasia has beeen reported, adequate epidemiological studies along these lines have not been conducted.

If pregnant or breast-feeding, ask a health professional before use. A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use.

Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

OTHER SAFETY INFORMATION

■ This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests

■ This product may stain contact lenses and other items if handled after touching tablets

■ long term administration of phenazopyridine HCI has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted

■ Store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light

DOSAGE & ADMINISTRATION SECTION

■ Adults and children 12 years of age and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor

■ Children under 12: Do not use wihout consulting a doctor

INACTIVE INGREDIENT SECTION

pregelatinized starch, microcrystalline cellulose, maize (corn) starch, povidone, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, hydroxypropyl methylcellulose, polyethylene glycol

OTC - QUESTIONS SECTION

call toll-free 1-845-547-2667

SPL UNCLASSIFIED SECTION

Size and color of tablets may vary.

*This product is not manufactured or distributed by the owner of the registered trademark AZO Urinary Pain Relief®.

Distributed by: Safrel Pharmaceuticals, LLC

Bridgewater, NJ 08807

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Compare to the active ingredient in AZO Urinary Pain Relief® Maximum Strength*

MAXIMUM STRENGTH

Urinary Pain Relief

PHENAZOPYRIDINE HYDROCHLORIDE 99.5 mg

Quickly eases urinary pain, burning & urgency

• More active ingredient for maximum relief

• Provides targeted relief for urinary pain

NDC 71309-779-72 - 72 Count

72 Count72 Count

NDC 71309-779-28- 28Count

28 Count28 Count

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1094147phenazopyridine HCl 99.5 MG Oral TabletPSN1
1094147phenazopyridine hydrochloride 99.5 MG Oral TabletSCD1
1094147phenazopyridine HCl 99.5 MG Oral TabletSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71309-779-282024-01-30C16284748780-11030e365-2321-111a-e063-dadaa90a10e2PHENAZOPYRIDINE HCL Tablet Maximum Strength
71309-779-722024-01-30C16284748780-11030e365-2321-111a-e063-dadaa90a10e2PHENAZOPYRIDINE HCL Tablet Maximum Strength

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71309-779-28Urinary Pain Relief28 in 1 BOTTLETABLET281
71309-779-72Urinary Pain Relief72 in 1 BOTTLETABLET721

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71309-779URINARY PAIN RELIEF (PHENAZOPYRIDINE HYDROCHLORIDE) TABLET [SAFREL PHARMACEUTICALS, LLC.]1Legacy NDC, 2 package rows20220814_e60ddbd8-5350-19e0-e053-2995a90ac67a.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71309-77971309-779-72, 71309-779-28

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e60ddefb-fd5e-b5df-e053-2a95a90a1b89e60ddbd8-5350-19e0-e053-2995a90ac67a2022-08-01WarningsExact identifier
spl id: e60ddefb-fd5e-b5df-e053-2a95a90a1b89
spl set id: e60ddbd8-5350-19e0-e053-2995a90ac67a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.